Skip to main content

iAnthus Capital Holdings, Inc. (ITHUF)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
35.2Poor

ValueMarkers Composite Index

Top 1%#44,094 of 44,707

DCF data not available

Piotroski
2/9
Weak
Beneish
-2.79
Low Risk
Altman
-7.22
Distress
DCF Value
-
N/A
ROIC
-7.7%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

iAnthus Capital Holdings, Inc. (ITHUF) — VMCI valuation read

ITHUF prints VMCI 35/100 inside the Healthcare sector, where the median sits at 50. The 15-point below-median delta is the cleanest single-number summary of iAnthus Capital Holdings, Inc.'s composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On ITHUF, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** ITHUF trades at 14.0x earnings, 22% below the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 0.7x leaves covenant headroom; that is the risk line for iAnthus Capital Holdings, Inc. on the trailing financials.

ITHUF fell 3.0% over the trailing 7 days, with a -19.1% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in ITHUF’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.